Screening and treatment intervention for insulin resistance/hyperinsulinemia hoping to prevent heart failure or slow its worsening.
Heart failure (HF) is the common endpoint of most heart diseases, affecting between 1 and 3% of the adult population worldwide, but increases to approximately 10% in adults over 70 years of age, exceeding 20% in those over 80-85 years of age [1, 2].
